Thierry Taverne

443 total citations
9 papers, 379 citations indexed

About

Thierry Taverne is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Thierry Taverne has authored 9 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Organic Chemistry, 4 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Thierry Taverne's work include Synthesis and biological activity (3 papers), Estrogen and related hormone effects (2 papers) and Inflammatory mediators and NSAID effects (2 papers). Thierry Taverne is often cited by papers focused on Synthesis and biological activity (3 papers), Estrogen and related hormone effects (2 papers) and Inflammatory mediators and NSAID effects (2 papers). Thierry Taverne collaborates with scholars based in France and Belgium. Thierry Taverne's co-authors include Laurent Désiré, Caroline Charlier, Raymond Houssin, Bertrand Leblond, Laurence Goossens, F. Durant, Jean‐François Goossens, Jean‐Pierre Hénichart, Nicole Pommery and Jean Pommery and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Thierry Taverne

9 papers receiving 365 citations

Peers

Thierry Taverne

MB

OC

PHARM

PHYSI

CB

Stephen J. Mnich United States

Laura Simone Italy

Zhengming Du United States

Mark D. Rosen United States

Jenson Qi United States

Masashi Kawanishi Japan

Angela Styhler Canada

Jennifer Lafontaine United States

John Herich United States

Toshiyuki Matsuno Japan

Stephen J. Mnich United States

Thierry Taverne

233 ×1.4

MB

106 ×0.6

OC

121 ×0.9

PHARM

46 ×1.1

PHYSI

19 ×0.5

CB

Citations per year, relative to Thierry Taverne Thierry Taverne (= 1×) peers Stephen J. Mnich

Countries citing papers authored by Thierry Taverne

Since Specialization

Citations

This map shows the geographic impact of Thierry Taverne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Taverne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Taverne more than expected).

Fields of papers citing papers by Thierry Taverne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Taverne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Taverne. The network helps show where Thierry Taverne may publish in the future.

Co-authorship network of co-authors of Thierry Taverne

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Taverne. A scholar is included among the top collaborators of Thierry Taverne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Taverne. Thierry Taverne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Hédou, Damien, Angélique Girard, Thierry Taverne, et al.. (2014). Design and Synthesis of Thiazolo[5,4-f]quinazolines as DYRK1A Inhibitors, Part II. Molecules. 19(10). 15411–15439. 44 indexed citations

2.

Bachelot, Florence, Catherine De Oliveira, Thierry Taverne, et al.. (2012). Vascular disrupting activity and the mechanism of action of EHT 6706, a novel anticancer tubulin polymerization inhibitor. Investigational New Drugs. 31(2). 304–319. 3 indexed citations

3.

Beausoleil, Eric, Thierry Taverne, S. Lacombe, et al.. (2009). Structure–activity relationship of isoform selective inhibitors of Rac1/1b GTPase nucleotide binding. Bioorganic & Medicinal Chemistry Letters. 19(19). 5594–5598. 14 indexed citations

4.

Désiré, Laurent, Virginie Picard, Catherine De Oliveira, et al.. (2005). RAC1 Inhibition Targets Amyloid Precursor Protein Processing by γ-Secretase and Decreases Aβ Production in Vitro and in Vivo. Journal of Biological Chemistry. 280(45). 37516–37525. 117 indexed citations

5.

Pommery, Nicole, Thierry Taverne, Laurence Goossens, et al.. (2004). New COX-2/5-LOX Inhibitors: Apoptosis-Inducing Agents Potentially Useful in Prostate Cancer Chemotherapy. Journal of Medicinal Chemistry. 47(25). 6195–6206. 106 indexed citations

6.

Génicot, Christophe, B. Christophe, Philippe Collart, et al.. (2003). Discovery of orally bioavailable NK1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(3). 437–442. 6 indexed citations

7.

Barbey, S., Laurence Goossens, Thierry Taverne, et al.. (2002). Synthesis and Activity of a New Methoxytetrahydropyran Derivative as Dual Cyclooxygenase-2/5-Lipoxygenase Inhibitor. Bioorganic & Medicinal Chemistry Letters. 12(5). 779–782. 52 indexed citations

8.

Taverne, Thierry, Ousmane Diouf, Patrick Depreux, et al.. (1998). Novel Benzothiazolin-2-one and Benzoxazin-3-one Arylpiperazine Derivatives with Mixed 5HT_1A/D₂Affinity as Potential Atypical Antipsychotics. Journal of Medicinal Chemistry. 41(12). 2010–2018. 36 indexed citations

9.

Taverne, Thierry, Patrick Depreux, Daniel Lesieur, Jean‐Pierre Hénichart, & Jacques H. Poupaert. (1997). AlCl3-DMF complex as catalyst in the Friedel-Craft reaction. The reactivity of anhydrides and chlorides of dicarboxylic acids.. DIAL (Catholic University of Leuven). 106(12). 791–801. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact